GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Cash Conversion Cycle

Lombard Medical Technologies (LSE:LMT) Cash Conversion Cycle : 253.38 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Lombard Medical Technologies's Days Sales Outstanding for the six months ended in Dec. 2012 was 84.07.
Lombard Medical Technologies's Days Inventory for the six months ended in Dec. 2012 was 287.31.
Lombard Medical Technologies's Days Payable for the six months ended in Dec. 2012 was 118.
Therefore, Lombard Medical Technologies's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2012 was 253.38.


Lombard Medical Technologies Cash Conversion Cycle Historical Data

The historical data trend for Lombard Medical Technologies's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Cash Conversion Cycle Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 110.83 198.68 168.41 188.43 235.67

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only 253.31 193.80 175.87 242.19 253.38

Competitive Comparison of Lombard Medical Technologies's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Cash Conversion Cycle falls into.



Lombard Medical Technologies Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Lombard Medical Technologies's Cash Conversion Cycle for the fiscal year that ended in Dec. 2012 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=91.72+312.6-168.65
=235.67

Lombard Medical Technologies's Cash Conversion Cycle for the quarter that ended in Dec. 2012 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=84.07+287.31-118
=253.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Lombard Medical Technologies Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.